Standardization of corneal alkali burn methodology in rabbits.
Villabona-Martinez V, Sampaio LP, Shiju TM, Wilson SE.
Exp Eye Res. 2023 May;230:109443. doi: 10.1016/j.exer.2023.109443. Epub 2023 Mar 21.
RIPK3-Mediated Necroptosis Drives Macrophage Infiltration and Corneal Neovascularization After Alkali Burn.
Li Y, Yang B, Chen Q, Zhou Y, Hu W, Huang X, Huang G, Tang N, Tang F, Huang H, Lan Q, He W, Xu F, Ye Y, Jiang L.
Invest Ophthalmol Vis Sci. 2025 Jun 2;66(6):54. doi: 10.1167/iovs.66.6.54.
Trimebutine prevents corneal inflammation in a rat alkali burn model.
Goto H, Arima T, Takahashi A, Tobita Y, Nakano Y, Toda E, Shimizu A, Okamoto F.
Sci Rep. 2024 May 27;14(1):12111. doi: 10.1038/s41598-024-61112-4.
Efficacy and safety of Fe-curcumin coordination polymer nanodots to prevent corneal neovascularization in alkali burn models.
Huo Y, Song L, Han Z, Yang Y, Wang T, Chen Z, Yang Q, Qiu Y, Huang W, Tao R, Cheng L, Kang L.
J Nanobiotechnology. 2025 Jul 16;23(1):518. doi: 10.1186/s12951-025-03555-z.
Sequential delivery of anti-inflammatory and anti-scar drugs by Rg3 liposome-embedded thiolated chitosan hydrogel eye drops for corneal alkali burn.
Tang H, Li X, Li C, Shen W, Jin L, Zhou Y, Jiao W, Zhang L, Cheng F.
Carbohydr Polym. 2025 Aug 1;361:123626. doi: 10.1016/j.carbpol.2025.123626. Epub 2025 Apr 21.
Transforming corneal alkali burn treatment: unveiling mechanisms and pioneering therapies from bench to bedside.
Xie M, Jie Y.
J Transl Med. 2025 Oct 21;23(1):1132. doi: 10.1186/s12967-025-07102-0.
miR-497 knockout aggravates alkali burn-induced corneal neovascularization via VEGFA and FGF2 pathways in mice models.
Guo W, Yang K, Yang W, Wu X, Pan Y, Xiang Y, Yang Y.
Int Ophthalmol. 2025 Aug 12;45(1):328. doi: 10.1007/s10792-025-03691-3.
Aloin alleviates corneal injury in alkali burn via inhibiting neutrophil extracellular traps and promoting Nrf2.
Zhao Z, Wen Y, Peng Y, Wang W, Ma H.
Immunopharmacol Immunotoxicol. 2024 Dec;46(6):773-784. doi: 10.1080/08923973.2024.2402365. Epub 2024 Sep 15.
Corneal alkali burn in mice: an update to adapt the model for comparative investigation of healing outcomes.
Khandokhin MM, Lobanova MA, Slobodkina EA, Makarevich PI, Eremichev RY.
Exp Eye Res. 2025 Oct;259:110523. doi: 10.1016/j.exer.2025.110523. Epub 2025 Jul 17.
Rapamycin inhibits corneal inflammatory response and neovascularization in a mouse model of corneal alkali burn.
Li J, Han J, Shi Y, Liu M.
Exp Eye Res. 2023 Aug;233:109539. doi: 10.1016/j.exer.2023.109539. Epub 2023 Jun 12.
